Publicaciones en colaboración con investigadores/as de David Geffen School of Medicine at UCLA (2)

2022

  1. Overcoming immunosuppression and pro-tumor inflammation in lung cancer with combined IL-1β and PD-1 inhibition

    Future Oncology, Vol. 18, Núm. 27, pp. 3085-3100

2021

  1. Canakinumab with and without pembrolizumab in patients with resectable non-small-cell lung cancer: CANOPY-N study design

    Future Oncology, Vol. 17, Núm. 12, pp. 1459-1472